Department of Cancer Genetics and Epigenetics, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.
Divisions of Chemistry and Chemical Engineering and Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Nucleic Acids Res. 2020 Jan 10;48(1):16-35. doi: 10.1093/nar/gkz1101.
DNA2 nuclease/helicase is a structure-specific nuclease, 5'-to-3' helicase, and DNA-dependent ATPase. It is involved in multiple DNA metabolic pathways, including Okazaki fragment maturation, replication of 'difficult-to-replicate' DNA regions, end resection, stalled replication fork processing, and mitochondrial genome maintenance. The participation of DNA2 in these different pathways is regulated by its interactions with distinct groups of DNA replication and repair proteins and by post-translational modifications. These regulatory mechanisms induce its recruitment to specific DNA replication or repair complexes, such as DNA replication and end resection machinery, and stimulate its efficient cleavage of various structures, for example, to remove RNA primers or to produce 3' overhangs at telomeres or double-strand breaks. Through these versatile activities at replication forks and DNA damage sites, DNA2 functions as both a tumor suppressor and promoter. In normal cells, it suppresses tumorigenesis by maintaining the genomic integrity. Thus, DNA2 mutations or functional deficiency may lead to cancer initiation. However, DNA2 may also function as a tumor promoter, supporting cancer cell survival by counteracting replication stress. Therefore, it may serve as an ideal target to sensitize advanced DNA2-overexpressing cancers to current chemo- and radiotherapy regimens.
DNA2 核酸酶/解旋酶是一种结构特异性核酸酶、5'-到-3'解旋酶和依赖于 DNA 的 ATP 酶。它参与多种 DNA 代谢途径,包括冈崎片段成熟、“难以复制”的 DNA 区域的复制、末端切除、停滞复制叉处理和线粒体基因组维持。DNA2 在这些不同途径中的参与受到其与不同组别的 DNA 复制和修复蛋白相互作用以及翻译后修饰的调节。这些调节机制诱导其募集到特定的 DNA 复制或修复复合物,例如 DNA 复制和末端切除机制,并刺激其有效切割各种结构,例如去除 RNA 引物或在端粒或双链断裂处产生 3'突出端。通过在复制叉和 DNA 损伤部位的这些多功能活性,DNA2 既作为肿瘤抑制因子又作为肿瘤促进因子发挥作用。在正常细胞中,它通过维持基因组完整性来抑制肿瘤发生。因此,DNA2 突变或功能缺失可能导致癌症的起始。然而,DNA2 也可能作为肿瘤促进因子发挥作用,通过抵消复制应激来支持癌细胞的存活。因此,它可以作为一个理想的靶点,使当前的化疗和放疗方案对高级别 DNA2 过表达的癌症更敏感。